<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2025-2-8-22</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-1967</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая трансплантология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical Transplantology</subject></subj-group></article-categories><title-group><article-title>Комбинированная последовательная гипотермическая оксигенированная и нормотермическая машинная перфузия трансплантата печени от донора с расширенными критериями: первый в РФ опыт применения в клинической практике</article-title><trans-title-group xml:lang="en"><trans-title>Combined sequential hypothermic oxygenated and normothermic machine perfusion for liver transplant from an expanded criteria donor: first clinical application in Russia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Готье</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gautier</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Готье Сергей Владимирович</p><p>Москва</p><p> </p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zbignev.religa@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Грудинин</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Grudinin</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Грудинин Никита Владимирович</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zbignev.religa@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Монахов</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Monakhov</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Монахов Артем Рашидович</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zbignev.religa@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Болдырев</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Boldyrev</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Болдырев Михаил Александрович</p><p>123182, Москва, ул. Щукинская, д. 1</p><p> </p></bio><bio xml:lang="en"><p>Mikhail А. Boldyrev</p><p>1, Shchukinskaya str., Moscow, 123182</p></bio><email xlink:type="simple">comex.ksb@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богданов</surname><given-names>В. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogdanov</surname><given-names>V. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бондаренко Владимир Константинович</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zbignev.religa@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бондаренко</surname><given-names>Д. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bondarenko</surname><given-names>D. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бондаренко Денис Михайлович</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zbignev.religa@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зубенко</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Zubenko</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зубенко Степан Игоревич</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zbignev.religa@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Можейко</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Mozheiko</surname><given-names>N. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Можейко Наталья Павловна</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zbignev.religa@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Минина</surname><given-names>М. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Minina</surname><given-names>M. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Минина Марина Геннадьевна</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zbignev.religa@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цирульникова</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsirulnikova</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цирульникова Ольга Мартеновна</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zbignev.religa@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России;&#13;
ФГАОУ ВО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России (Сеченовский университет)<country>Россия</country></aff><aff xml:lang="en">Shumakov National Medical Research Center of Transplantology and Artificial Organs;&#13;
Sechenov University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России<country>Россия</country></aff><aff xml:lang="en">Shumakov National Medical Research Center of Transplantology and Artificial Organ<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России;&#13;
ГБУЗ «Московский многопрофильный научно-клинический центр имени С.П. Боткина Департамента здравоохранения города Москвы»<country>Россия</country></aff><aff xml:lang="en">Shumakov National Medical Research Center of Transplantology and Artificial Organ;&#13;
Botkin Hospital<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>12</day><month>07</month><year>2025</year></pub-date><volume>27</volume><issue>2</issue><fpage>8</fpage><lpage>22</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Готье С.В., Грудинин Н.В., Монахов А.Р., Болдырев М.А., Богданов В.К., Бондаренко Д.М., Зубенко С.И., Можейко Н.П., Минина М.Г., Цирульникова О.М., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Готье С.В., Грудинин Н.В., Монахов А.Р., Болдырев М.А., Богданов В.К., Бондаренко Д.М., Зубенко С.И., Можейко Н.П., Минина М.Г., Цирульникова О.М.</copyright-holder><copyright-holder xml:lang="en">Gautier S.V., Grudinin N.V., Monakhov A.R., Boldyrev M.A., Bogdanov V.K., Bondarenko D.M., Zubenko S.I., Mozheiko N.P., Minina M.G., Tsirulnikova O.M.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/1967">https://journal.transpl.ru/vtio/article/view/1967</self-uri><abstract><sec><title>Цель</title><p>Цель: проанализировать серию случаев и оценить безопасность и эффективность применения в клинической практике протокола комбинированной последовательной двойной гипотермической оксигенированной (D-НОРЕ) и нормотермической (NMP) машинной перфузии с целью кондиционирования и оценки жизнеспособности трансплантатов печени от доноров с расширенными критериями (ДРК).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы: с ноября по декабрь 2024 года в НМИЦ ТИО было проведено два сеанса комбинированной D-HOPE и NMP аллографтов печени, полученных от ДРК со смертью головного мозга. Перфузия проводилась с использованием аппарата ИК после предшествующего периода статической фармакохолодовой консервации (СФХК). Использовался перфузат на основе раствора HTK и эритроцитарной взвеси для этапов D-HOPE и NMP соответственно. Перфузия проводилась с поддержанием параметров температуры и гемодинамики и оценки лабораторных показателей согласно разработанному в НМИЦ ТИО протоколу.</p></sec><sec><title>Результаты</title><p>Результаты: в результате перфузии аллографт №1 был признан нежизнеспособным из-за роста уровня лактата после 3 часов перфузии и отсутствия метаболизма глюкозы. Срок СФХК составил 424 мин, D-HOPE - 120 мин, NMP - 300 минут, общее время консервации - 844 минуты. Аллографт №2 достиг критериев жизнеспособности и был успешно трансплантирован. Срок СФХК составил 260 минут, D-HOPE и NMP - 124 и 480 минут соответственно. Общее время консервации составило 884 минуты. Пиковые значения АСТ, АЛТ и общего билирубина  у реципиента составили 922,5 ед/л, 613 ед/л и 63,3 мкмоль/л соответственно. Единственным осложнением у реципиента было острое почечное повреждение, потребовавшее проведения 2 сеансов гемодиализа. Срок госпитализации составил 14 дней без необходимости повторных госпитализаций. На момент написания работы пациент жив без осложнений, срок наблюдения составил 3 месяца.</p></sec><sec><title>Заключение</title><p>Заключение: Комбинированная машинная перфузия трансплантатов печени - безопасная и эффективная методика, позволяющая уменьшить ишемически-реперфузионно-консервационное повреждение и оценить жизнеспособность маргинальных трансплантатов печени, а также уменьшить количество потенциальных осложнений у реципиента и расширить донорский пул за счет использования аллографтов от ДРК.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to analyze a clinical case series and evaluate the safety and efficacy of a sequential machine perfusion protocol combining dual hypothermic oxygenated perfusion (D-HOPE) and normothermic machine perfusion (NMP) for conditioning and viability assessment of liver grafts retrieved from expanded criteria donors (ECD) in routine clinical practice.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Between November and December 2024, two sessions of combined D-HOPE followed by NMP were conducted at Shumakov National Medical Research Center of Transplantology and Artificial Organs («Shumakov Research Center») using liver allografts obtained from ECD after brain death. Following an initial period of static cold storage (SCS), machine perfusion was initiated using a circulatory assist device. A histidine-tryptophan-ketoglutarate (HTK)-based perfusate was used during the DHOPE phase, while a red blood cell (RBC) suspension was used during the NMP stage. Throughout perfusion, temperature and hemodynamic parameters were continuously monitored and maintained. Laboratory parameters were assessed at designated intervals, in accordance with the institutional protocol developed at Shumakov Research Center.</p></sec><sec><title>Results</title><p>Results. Allograft #1 was deemed non-viable due to elevated lactate levels after 3 hours of perfusion and lack of glucose metabolism. The preservation times were as follows: SCS – 424 minutes, D-HOPE – 120 minutes, NMP – 300 minutes, totaling 844 minutes. Allograft #2 met the viability criteria and was successfully transplanted. Preservation times were: SCS – 260 minutes, D-HOPE – 124 minutes, NMP – 480 minutes, with a total preservation time of 884 minutes. Post-transplant peak levels of AST, ALT, and total bilirubin in the recipient were 922.5 U/L, 613 U/L, and 63.3 μmol/L, respectively. The only postoperative complication was acute kidney injury, managed with two sessions of hemodialysis. The patient was discharged after 14 days of hospitalization without need for readmission. At the time of writing, the patient is alive and complication-free, with a follow-up period of 3 months.</p></sec><sec><title>Conclusions</title><p>Conclusions. Combined machine perfusion of liver grafts appears to be a safe and effective strategy to mitigate ischemia-reperfusion and preservation-related injury in liver transplantation. It also facilitates viability assessment of marginal liver grafts, reduces potential recipient complications, and expands the donor pool through the use of allografts from ECD.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ex vivo перфузия</kwd><kwd>трансплантация печени</kwd><kwd>машинная перфузия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ex vivo perfusion</kwd><kwd>liver transplantation</kwd><kwd>machine perfusion</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis A, Koukoura A, Tsianos GI, Gargavanis AA, Nielsen AA, Vassiliadis E. Organ donation in the US and Europe: The supply vs demand imbalance. Transplant Rev (Orlando). 2021 Apr; 35 (2): 100585. doi: 10.1016/j.trre.2020.100585. Epub 2020 Oct 11. PMID: 33071161.</mixed-citation><mixed-citation xml:lang="en">Lewis A, Koukoura A, Tsianos GI, Gargavanis AA, Nielsen AA, Vassiliadis E. Organ donation in the US and Europe: The supply vs demand imbalance. Transplant Rev (Orlando). 2021 Apr; 35 (2): 100585. doi: 10.1016/j.trre.2020.100585. Epub 2020 Oct 11. PMID: 33071161.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Langone AJ, Helderman JH. Disparity between solidorgan supply and demand. N Engl J Med. 2003 Aug 14; 349 (7): 704–706. doi: 10.1056/NEJMe038117. PMID: 12917309.</mixed-citation><mixed-citation xml:lang="en">Langone AJ, Helderman JH. Disparity between solidorgan supply and demand. N Engl J Med. 2003 Aug 14; 349 (7): 704–706. doi: 10.1056/NEJMe038117. PMID: 12917309.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kwong AJ, Kim WR, Lake JR, Schladt DP, Schnellinger EM, Gauntt K et al. OPTN/SRTR 2022 Annual Data Report: Liver. Am J Transplant. 2024 Feb; 24 (2S1): S176–S265. doi: 10.1016/j.ajt.2024.01.014. PMID: 38431359.</mixed-citation><mixed-citation xml:lang="en">Kwong AJ, Kim WR, Lake JR, Schladt DP, Schnellinger EM, Gauntt K et al. OPTN/SRTR 2022 Annual Data Report: Liver. Am J Transplant. 2024 Feb; 24 (2S1): S176–S265. doi: 10.1016/j.ajt.2024.01.014. PMID: 38431359.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Goldaracena N, Cullen JM, Kim DS, Ekser B, Halazun KJ. Expanding the donor pool for liver transplantation with marginal donors. Int J Surg. 2020 Oct; 82S: 30–35. doi: 10.1016/j.ijsu.2020.05.024. Epub 2020 May 15. PMID: 32422385.</mixed-citation><mixed-citation xml:lang="en">Goldaracena N, Cullen JM, Kim DS, Ekser B, Halazun KJ. Expanding the donor pool for liver transplantation with marginal donors. Int J Surg. 2020 Oct; 82S: 30–35. doi: 10.1016/j.ijsu.2020.05.024. Epub 2020 May 15. PMID: 32422385.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Moein M, Bahreini A, Razavi A, Badie S, Coyle S, Abedini M et al. A Review of Long-Term Outcomes of Liver Transplantation Using Extended Criteria Donors in the United States. J Surg Res. 2025 Feb; 306: 561–569. doi: 10.1016/j.jss.2024.12.055. Epub 2025 Jan 31. PMID: 39892300.</mixed-citation><mixed-citation xml:lang="en">Moein M, Bahreini A, Razavi A, Badie S, Coyle S, Abedini M et al. A Review of Long-Term Outcomes of Liver Transplantation Using Extended Criteria Donors in the United States. J Surg Res. 2025 Feb; 306: 561–569. doi: 10.1016/j.jss.2024.12.055. Epub 2025 Jan 31. PMID: 39892300.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang T, Dunson J, Kanwal F, Galvan NTN, Vierling JM, O’Mahony C et al. Trends in Outcomes for Marginal Allografts in Liver Transplant. JAMA Surg. 2020 Aug 5; 155 (10): 926–32. doi: 10.1001/jamasurg.2020.2484. Epub ahead of print. Erratum in: JAMA Surg. 2020 Oct 1; 155 (10): 1002. doi: 10.1001/jamasurg.2020.4315. PMID: 32777009; PMCID: PMC7407315.</mixed-citation><mixed-citation xml:lang="en">Zhang T, Dunson J, Kanwal F, Galvan NTN, Vierling JM, O’Mahony C et al. Trends in Outcomes for Marginal Allografts in Liver Transplant. JAMA Surg. 2020 Aug 5; 155 (10): 926–32. doi: 10.1001/jamasurg.2020.2484. Epub ahead of print. Erratum in: JAMA Surg. 2020 Oct 1; 155 (10): 1002. doi: 10.1001/jamasurg.2020.4315. PMID: 32777009; PMCID: PMC7407315.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation. 1992 May; 53 (5): 957–978. doi: 10.1097/00007890-199205000-00001. PMID: 1585489.</mixed-citation><mixed-citation xml:lang="en">Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation. 1992 May; 53 (5): 957–978. doi: 10.1097/00007890-199205000-00001. PMID: 1585489.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lozanovski VJ, Probst P, Arefidoust A, Ramouz A, Aminizadeh E, Nikdad M et al. Prognostic role of the Donor Risk Index, the Eurotransplant Donor Risk Index, and the Balance of Risk score on graft loss after liver transplantation. Transpl Int. 2021 May; 34 (5): 778–800. doi: 10.1111/tri.13861. Epub 2021 May 1. PMID: 33728724.</mixed-citation><mixed-citation xml:lang="en">Lozanovski VJ, Probst P, Arefidoust A, Ramouz A, Aminizadeh E, Nikdad M et al. Prognostic role of the Donor Risk Index, the Eurotransplant Donor Risk Index, and the Balance of Risk score on graft loss after liver transplantation. Transpl Int. 2021 May; 34 (5): 778–800. doi: 10.1111/tri.13861. Epub 2021 May 1. PMID: 33728724.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">De Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D et al. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. J Gastroenterol Hepatol. 2012 Mar; 27 (3): 540–546. doi: 10.1111/j.1440-1746.2011.06844.x. PMID: 21777274.</mixed-citation><mixed-citation xml:lang="en">De Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D et al. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. J Gastroenterol Hepatol. 2012 Mar; 27 (3): 540–546. doi: 10.1111/j.1440-1746.2011.06844.x. PMID: 21777274.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Callaghan CJ, Charman SC, Muiesan P, Powell JJ, Gimson AE, van der Meulen JH; UK Liver Transplant Audit. Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open. 2013 Sep 3; 3 (9): e003287. doi: 10.1136/bmjopen-2013-003287. PMID: 24002984; PMCID: PMC3773642.</mixed-citation><mixed-citation xml:lang="en">Callaghan CJ, Charman SC, Muiesan P, Powell JJ, Gimson AE, van der Meulen JH; UK Liver Transplant Audit. Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open. 2013 Sep 3; 3 (9): e003287. doi: 10.1136/bmjopen-2013-003287. PMID: 24002984; PMCID: PMC3773642.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Van Leeuwen OB, Bodewes SB, Lantinga VA, Haring MPD, Thorne AM, Brüggenwirth IMA et al. Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers. Am J Transplant. 2022 Jun; 22 (6): 1658–1670. doi: 10.1111/ajt.17022. Epub 2022 Apr 18. PMID: 35286759; PMCID: PMC9325426.</mixed-citation><mixed-citation xml:lang="en">Van Leeuwen OB, Bodewes SB, Lantinga VA, Haring MPD, Thorne AM, Brüggenwirth IMA et al. Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers. Am J Transplant. 2022 Jun; 22 (6): 1658–1670. doi: 10.1111/ajt.17022. Epub 2022 Apr 18. PMID: 35286759; PMCID: PMC9325426.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mergental H, Laing RW, Kirkham AJ, Clarke G, Boteon YL, Barton D et al. Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes. Liver Transpl. 2024 Jan 1; 30 (1): 30–45. doi: 10.1097/LVT.0000000000000270. Epub 2023 Dec 15. PMID: 38109282.</mixed-citation><mixed-citation xml:lang="en">Mergental H, Laing RW, Kirkham AJ, Clarke G, Boteon YL, Barton D et al. Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes. Liver Transpl. 2024 Jan 1; 30 (1): 30–45. doi: 10.1097/LVT.0000000000000270. Epub 2023 Dec 15. PMID: 38109282.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dutkowski P, Polak WG, Muiesan P, Schlegel A, Verhoeven CJ, Scalera I et al. First Comparison of Hypothermic Oxygenated PErfusion Versus Static Cold Storage of Human Donation After Cardiac Death Liver Transplants: An International-matched Case Analysis. Ann Surg. 2015 Nov; 262 (5): 764–770; discussion 770– 771. doi: 10.1097/SLA.0000000000001473. PMID: 26583664.</mixed-citation><mixed-citation xml:lang="en">Dutkowski P, Polak WG, Muiesan P, Schlegel A, Verhoeven CJ, Scalera I et al. First Comparison of Hypothermic Oxygenated PErfusion Versus Static Cold Storage of Human Donation After Cardiac Death Liver Transplants: An International-matched Case Analysis. Ann Surg. 2015 Nov; 262 (5): 764–770; discussion 770– 771. doi: 10.1097/SLA.0000000000001473. PMID: 26583664.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Van Rijn R, Schurink IJ, de Vries Y, van den Berg AP, Cortes Cerisuelo M, Darwish Murad S et al. Hypothermic Machine Perfusion in Liver Transplantation – A Randomized Trial. N Engl J Med. 2021 Apr 15; 384 (15): 1391–1401. doi: 10.1056/NEJMoa2031532. Epub 2021 Feb 24. PMID: 33626248.</mixed-citation><mixed-citation xml:lang="en">Van Rijn R, Schurink IJ, de Vries Y, van den Berg AP, Cortes Cerisuelo M, Darwish Murad S et al. Hypothermic Machine Perfusion in Liver Transplantation – A Randomized Trial. N Engl J Med. 2021 Apr 15; 384 (15): 1391–1401. doi: 10.1056/NEJMoa2031532. Epub 2021 Feb 24. PMID: 33626248.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Nasralla D, Coussios CC, Mergental H, Akhtar MZ, Butler AJ, Ceresa CDL et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018 May; 557 (7703): 50–56. doi: 10.1038/s41586-018-0047-9. Epub 2018 Apr 18. PMID: 29670285.</mixed-citation><mixed-citation xml:lang="en">Nasralla D, Coussios CC, Mergental H, Akhtar MZ, Butler AJ, Ceresa CDL et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018 May; 557 (7703): 50–56. doi: 10.1038/s41586-018-0047-9. Epub 2018 Apr 18. PMID: 29670285.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Markmann JF, Vagefi PA, MacConmara MP. Normothermic Machine Perfusion Increases Donor Liver Use. JAMA Surg. 2022 Aug 1; 157 (8): 742–743. doi: 10.1001/jamasurg.2022.1424. PMID: 35507357.</mixed-citation><mixed-citation xml:lang="en">Markmann JF, Vagefi PA, MacConmara MP. Normothermic Machine Perfusion Increases Donor Liver Use. JAMA Surg. 2022 Aug 1; 157 (8): 742–743. doi: 10.1001/jamasurg.2022.1424. PMID: 35507357.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Eden J, Thorne AM, Bodewes SB, Patrono D, Roggio D, Breuer E et al. Assessment of liver graft quality during hypothermic oxygenated perfusion: The first international validation study. J Hepatol. 2025 Mar; 82 (3): 523– 534. doi: 10.1016/j.jhep.2024.08.030. Epub 2024 Sep 7. PMID: 39251091; PMCID: PMC11830552.</mixed-citation><mixed-citation xml:lang="en">Eden J, Thorne AM, Bodewes SB, Patrono D, Roggio D, Breuer E et al. Assessment of liver graft quality during hypothermic oxygenated perfusion: The first international validation study. J Hepatol. 2025 Mar; 82 (3): 523– 534. doi: 10.1016/j.jhep.2024.08.030. Epub 2024 Sep 7. PMID: 39251091; PMCID: PMC11830552.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Van Leeuwen OB, Lantinga VA, Lascaris B, Thorne AM, Bodewes SB, Nijsten MW et al. ‘Back-to-base’ combined hypothermic and normothermic machine perfusion of human donor livers. Nat Protoc. 2025. https://doi.org/10.1038/s41596-024-01130-8.</mixed-citation><mixed-citation xml:lang="en">Van Leeuwen OB, Lantinga VA, Lascaris B, Thorne AM, Bodewes SB, Nijsten MW et al. ‘Back-to-base’ combined hypothermic and normothermic machine perfusion of human donor livers. Nat Protoc. 2025. https://doi.org/10.1038/s41596-024-01130-8.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Watson CJE, Kosmoliaptsis V, Randle LV, Gimson AE, Brais R, Klinck JR et al. Normothermic Perfusion in the Assessment and Preservation of Declined Livers Before Transplantation: Hyperoxia and VasoplegiaImportant Lessons From the First 12 Cases. Transplantation. 2017 May; 101 (5): 1084–1098. doi: 10.1097/TP.0000000000001661. PMID: 28437389; PMCID: PMC5642347.</mixed-citation><mixed-citation xml:lang="en">Watson CJE, Kosmoliaptsis V, Randle LV, Gimson AE, Brais R, Klinck JR et al. Normothermic Perfusion in the Assessment and Preservation of Declined Livers Before Transplantation: Hyperoxia and VasoplegiaImportant Lessons From the First 12 Cases. Transplantation. 2017 May; 101 (5): 1084–1098. doi: 10.1097/TP.0000000000001661. PMID: 28437389; PMCID: PMC5642347.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Mergental H, Laing RW, Kirkham AJ, Perera MTPR, Boteon YL, Attard J et al. Transplantation of discarded livers following viability testing with normothermic machine perfusion. Nat Commun. 2020 Jun 16; 11 (1): 2939. doi: 10.1038/s41467-020-16251-3. PMID: 32546694; PMCID: PMC7298000.</mixed-citation><mixed-citation xml:lang="en">Mergental H, Laing RW, Kirkham AJ, Perera MTPR, Boteon YL, Attard J et al. Transplantation of discarded livers following viability testing with normothermic machine perfusion. Nat Commun. 2020 Jun 16; 11 (1): 2939. doi: 10.1038/s41467-020-16251-3. PMID: 32546694; PMCID: PMC7298000.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Minor T, von Horn C, Zlatev H, Saner F, Grawe M, Lüer B et al. Controlled oxygenated rewarming as novel end-ischemic therapy for cold stored liver grafts. A randomized controlled trial. Clin Transl Sci. 2022 Dec; 15 (12): 2918–2927. doi: 10.1111/cts.13409. Epub 2022 Oct 17. PMID: 36251938; PMCID: PMC9747115.</mixed-citation><mixed-citation xml:lang="en">Minor T, von Horn C, Zlatev H, Saner F, Grawe M, Lüer B et al. Controlled oxygenated rewarming as novel end-ischemic therapy for cold stored liver grafts. A randomized controlled trial. Clin Transl Sci. 2022 Dec; 15 (12): 2918–2927. doi: 10.1111/cts.13409. Epub 2022 Oct 17. PMID: 36251938; PMCID: PMC9747115.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Hoyer DP, Mathé Z, Gallinat A, Canbay AC, Treckmann JW, Rauen U et al. Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept. Transplantation. 2016 Jan; 100 (1): 147–152. doi: 10.1097/TP.0000000000000915. PMID: 26479280.</mixed-citation><mixed-citation xml:lang="en">Hoyer DP, Mathé Z, Gallinat A, Canbay AC, Treckmann JW, Rauen U et al. Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept. Transplantation. 2016 Jan; 100 (1): 147–152. doi: 10.1097/TP.0000000000000915. PMID: 26479280.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Q, Del Prete L, Ali K, Grady P, Bilancini M, Etterling J et al. Sequential hypothermic and normothermic perfusion preservation and transplantation of expanded criteria donor livers. Surgery. 2023 Mar; 173 (3): 846– 854. doi: 10.1016/j.surg.2022.07.035. Epub 2022 Oct 24. PMID: 36302699.</mixed-citation><mixed-citation xml:lang="en">Liu Q, Del Prete L, Ali K, Grady P, Bilancini M, Etterling J et al. Sequential hypothermic and normothermic perfusion preservation and transplantation of expanded criteria donor livers. Surgery. 2023 Mar; 173 (3): 846– 854. doi: 10.1016/j.surg.2022.07.035. Epub 2022 Oct 24. PMID: 36302699.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">De Vries Y, Matton APM, Nijsten MWN, Werner MJM, van den Berg AP, de Boer MT et al. Pretransplant sequential hypo- and normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution. Am J Transplant. 2019 Apr; 19 (4): 1202–1211. doi: 10.1111/ajt.15228. Epub 2019 Jan 23. PMID: 30588774; PMCID: PMC6590255.</mixed-citation><mixed-citation xml:lang="en">De Vries Y, Matton APM, Nijsten MWN, Werner MJM, van den Berg AP, de Boer MT et al. Pretransplant sequential hypo- and normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution. Am J Transplant. 2019 Apr; 19 (4): 1202–1211. doi: 10.1111/ajt.15228. Epub 2019 Jan 23. PMID: 30588774; PMCID: PMC6590255.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Oosterlee A, Rahmel A. Eurotransplant International Foundation Annual Report 2008. 2011.</mixed-citation><mixed-citation xml:lang="en">Oosterlee A, Rahmel A. Eurotransplant International Foundation Annual Report 2008. 2011.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006 Apr; 6 (4): 783–790. doi: 10.1111/j.1600-6143.2006.01242.x. Erratum in: Am J Transplant. 2018 Dec; 18 (12): 3085. doi: 10.1111/ajt.15155. PMID: 16539636.</mixed-citation><mixed-citation xml:lang="en">Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006 Apr; 6 (4): 783–790. doi: 10.1111/j.1600-6143.2006.01242.x. Erratum in: Am J Transplant. 2018 Dec; 18 (12): 3085. doi: 10.1111/ajt.15155. PMID: 16539636.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Martínez JA, Pacheco S, Bachler JP, Jarufe N, Briceño E, Guerra JF et al. Accuracy of the BAR score in the prediction of survival after liver transplantation. Ann Hepatol. 2019 Mar-Apr; 18 (2): 386–392. doi: 10.1016/j.aohep.2019.01.002. Epub 2019 Apr 17. PMID: 31036493.</mixed-citation><mixed-citation xml:lang="en">Martínez JA, Pacheco S, Bachler JP, Jarufe N, Briceño E, Guerra JF et al. Accuracy of the BAR score in the prediction of survival after liver transplantation. Ann Hepatol. 2019 Mar-Apr; 18 (2): 386–392. doi: 10.1016/j.aohep.2019.01.002. Epub 2019 Apr 17. PMID: 31036493.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Погребниченко ИВ. Эффективное использование печени мультиорганного донора для трансплантации: дис. … канд. мед. наук. М., 2014; 143.</mixed-citation><mixed-citation xml:lang="en">Pogrebnichenko IV. Effektivnoe ispol’zovanie pecheni mul’tiorgannogo donora dlya transplantatsii: dis. … kand. med. nauk. M., 2014; 143.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Koch DT, Tamai M, Schirren M, Drefs M, Jacobi S, Lange CM et al. Mono-HOPE Versus Dual-HOPE in Liver Transplantation: A Propensity Score-Matched Evaluation of Early Graft Outcome. Transpl Int. 2025 Feb 5; 38: 13891. doi: 10.3389/ti.2025.13891. PMID: 39974599; PMCID: PMC11835512.</mixed-citation><mixed-citation xml:lang="en">Koch DT, Tamai M, Schirren M, Drefs M, Jacobi S, Lange CM et al. Mono-HOPE Versus Dual-HOPE in Liver Transplantation: A Propensity Score-Matched Evaluation of Early Graft Outcome. Transpl Int. 2025 Feb 5; 38: 13891. doi: 10.3389/ti.2025.13891. PMID: 39974599; PMCID: PMC11835512.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">De Vries Y, Brüggenwirth IMA, Karangwa SA, von Meijenfeldt FA, van Leeuwen OB, Burlage LC et al. Dual Versus Single Oxygenated Hypothermic Machine Perfusion of Porcine Livers: Impact on Hepatobiliary and Endothelial Cell Injury. Transplant Direct. 2021 Aug 5; 7 (9): e741. doi: 10.1097/TXD.0000000000001184. PMID: 34386578; PMCID: PMC8354629.</mixed-citation><mixed-citation xml:lang="en">De Vries Y, Brüggenwirth IMA, Karangwa SA, von Meijenfeldt FA, van Leeuwen OB, Burlage LC et al. Dual Versus Single Oxygenated Hypothermic Machine Perfusion of Porcine Livers: Impact on Hepatobiliary and Endothelial Cell Injury. Transplant Direct. 2021 Aug 5; 7 (9): e741. doi: 10.1097/TXD.0000000000001184. PMID: 34386578; PMCID: PMC8354629.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Sousa Da Silva RX, Weber A, Dutkowski P, Clavien PA. Machine perfusion in liver transplantation. Hepatology. 2022 Nov; 76 (5): 1531–1549. doi: 10.1002/hep.32546. Epub 2022 May 17. PMID: 35488496.</mixed-citation><mixed-citation xml:lang="en">Sousa Da Silva RX, Weber A, Dutkowski P, Clavien PA. Machine perfusion in liver transplantation. Hepatology. 2022 Nov; 76 (5): 1531–1549. doi: 10.1002/hep.32546. Epub 2022 May 17. PMID: 35488496.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Schlegel A, Muller X, Mueller M, Stepanova A, Kron P, de Rougemont O et al. Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation. EBioMedicine. 2020 Oct; 60: 103014. doi: 10.1016/j.ebiom.2020.103014. Epub 2020 Sep 24. PMID: 32979838; PMCID: PMC7519249.</mixed-citation><mixed-citation xml:lang="en">Schlegel A, Muller X, Mueller M, Stepanova A, Kron P, de Rougemont O et al. Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation. EBioMedicine. 2020 Oct; 60: 103014. doi: 10.1016/j.ebiom.2020.103014. Epub 2020 Sep 24. PMID: 32979838; PMCID: PMC7519249.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Eden J, Breuer E, Birrer D, Müller M, Pfister M, Mayr H et al. Screening for mitochondrial function before useroutine liver assessment during hypothermic oxygenated perfusion impacts liver utilization. EBioMedicine. 2023 Dec; 98: 104857. doi: 10.1016/j.ebiom.2023.104857. Epub 2023 Oct 31. PMID: 37918219; PMCID: PMC10641151.</mixed-citation><mixed-citation xml:lang="en">Eden J, Breuer E, Birrer D, Müller M, Pfister M, Mayr H et al. Screening for mitochondrial function before useroutine liver assessment during hypothermic oxygenated perfusion impacts liver utilization. EBioMedicine. 2023 Dec; 98: 104857. doi: 10.1016/j.ebiom.2023.104857. Epub 2023 Oct 31. PMID: 37918219; PMCID: PMC10641151.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Patrono D, Catalano G, Rizza G, Lavorato N, Berchialla P, Gambella A et al. Perfusate Analysis During Dual Hypothermic Oxygenated Machine Perfusion of Liver Grafts: Correlations With Donor Factors and Early Outcomes. Transplantation. 2020 Sep; 104 (9): 1929–1942. doi: 10.1097/TP.0000000000003398. PMID: 32769628.</mixed-citation><mixed-citation xml:lang="en">Patrono D, Catalano G, Rizza G, Lavorato N, Berchialla P, Gambella A et al. Perfusate Analysis During Dual Hypothermic Oxygenated Machine Perfusion of Liver Grafts: Correlations With Donor Factors and Early Outcomes. Transplantation. 2020 Sep; 104 (9): 1929–1942. doi: 10.1097/TP.0000000000003398. PMID: 32769628.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Groen PC, van Leeuwen OB, de Jonge J, Porte RJ. Viability assessment of the liver during ex situ machine perfusion prior to transplantation. Curr Opin Organ Transplant. 2024 Aug 1; 29 (4): 239–247. doi: 10.1097/MOT.0000000000001152. Epub 2024 May 17. PMID: 38764406; PMCID: PMC11224566.</mixed-citation><mixed-citation xml:lang="en">Groen PC, van Leeuwen OB, de Jonge J, Porte RJ. Viability assessment of the liver during ex situ machine perfusion prior to transplantation. Curr Opin Organ Transplant. 2024 Aug 1; 29 (4): 239–247. doi: 10.1097/MOT.0000000000001152. Epub 2024 May 17. PMID: 38764406; PMCID: PMC11224566.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Jeddou H, Tzedakis S, Chaouch MA, Sulpice L, Samson M, Boudjema K. Viability Assessment During Normothermic Machine Liver Perfusion: A Literature Review. Liver Int. 2025 Feb; 45 (2): e16244. doi: 10.1111/liv.16244. PMID: 39821671; PMCID: PMC11740183.</mixed-citation><mixed-citation xml:lang="en">Jeddou H, Tzedakis S, Chaouch MA, Sulpice L, Samson M, Boudjema K. Viability Assessment During Normothermic Machine Liver Perfusion: A Literature Review. Liver Int. 2025 Feb; 45 (2): e16244. doi: 10.1111/liv.16244. PMID: 39821671; PMCID: PMC11740183.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Matton APM, de Vries Y, Burlage LC, van Rijn R, Fujiyoshi M, de Meijer VE et al. Biliary Bicarbonate, pH, and Glucose Are Suitable Biomarkers of Biliary Viability During Ex Situ Normothermic Machine Perfusion of Human Donor Livers. Transplantation. 2019 Jul; 103 (7): 1405–1413. doi: 10.1097/TP.0000000000002500. PMID: 30395120; PMCID: PMC6613725.</mixed-citation><mixed-citation xml:lang="en">Matton APM, de Vries Y, Burlage LC, van Rijn R, Fujiyoshi M, de Meijer VE et al. Biliary Bicarbonate, pH, and Glucose Are Suitable Biomarkers of Biliary Viability During Ex Situ Normothermic Machine Perfusion of Human Donor Livers. Transplantation. 2019 Jul; 103 (7): 1405–1413. doi: 10.1097/TP.0000000000002500. PMID: 30395120; PMCID: PMC6613725.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010 Aug; 16 (8): 943–949. doi: 10.1002/lt.22091. PMID: 20677285.</mixed-citation><mixed-citation xml:lang="en">Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010 Aug; 16 (8): 943–949. doi: 10.1002/lt.22091. PMID: 20677285.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120 (4): c179–c184. doi: 10.1159/000339789. Epub 2012 Aug 7. PMID: 22890468.</mixed-citation><mixed-citation xml:lang="en">Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120 (4): c179–c184. doi: 10.1159/000339789. Epub 2012 Aug 7. PMID: 22890468.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Freah MAB, McPhail MJW, Dionigi E, Foxton MR, Auzinger G, Rela M et al. Improving the Diagnostic Criteria for Primary Liver Graft Nonfunction in Adults Utilizing Standard and Transportable Laboratory Parameters: An Outcome-Based Analysis. Am J Transplant. 2017 May; 17 (5): 1255–1266. doi: 10.1111/ajt.14230. Epub 2017 Apr 5. PMID: 28199762.</mixed-citation><mixed-citation xml:lang="en">Al-Freah MAB, McPhail MJW, Dionigi E, Foxton MR, Auzinger G, Rela M et al. Improving the Diagnostic Criteria for Primary Liver Graft Nonfunction in Adults Utilizing Standard and Transportable Laboratory Parameters: An Outcome-Based Analysis. Am J Transplant. 2017 May; 17 (5): 1255–1266. doi: 10.1111/ajt.14230. Epub 2017 Apr 5. PMID: 28199762.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Eshmuminov D, Becker D, Bautista Borrego L, Hefti M, Schuler MJ, Hagedorn C et al. An integrated perfusion machine preserves injured human livers for 1 week. Nat Biotechnol. 2020 Feb; 38 (2): 189–198. doi: 10.1038/s41587-019-0374-x. Epub 2020 Jan 13. PMID: 31932726; PMCID: PMC7008032.</mixed-citation><mixed-citation xml:lang="en">Eshmuminov D, Becker D, Bautista Borrego L, Hefti M, Schuler MJ, Hagedorn C et al. An integrated perfusion machine preserves injured human livers for 1 week. Nat Biotechnol. 2020 Feb; 38 (2): 189–198. doi: 10.1038/s41587-019-0374-x. Epub 2020 Jan 13. PMID: 31932726; PMCID: PMC7008032.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Schurink IJ, Willemse J, Verstegen MMA, van der Laan LJW, de Jonge J. Long-Term Perfusion of the Liver Outside the Body: Warming Up for Ex vivo Therapies? Hepatology. 2020 Oct; 72 (4): 1485–1487. doi: 10.1002/hep.31474. PMID: 33464565; PMCID: PMC7702161.</mixed-citation><mixed-citation xml:lang="en">Schurink IJ, Willemse J, Verstegen MMA, van der Laan LJW, de Jonge J. Long-Term Perfusion of the Liver Outside the Body: Warming Up for Ex vivo Therapies? Hepatology. 2020 Oct; 72 (4): 1485–1487. doi: 10.1002/hep.31474. PMID: 33464565; PMCID: PMC7702161.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Olumba FC, Zhou F, Park Y, Chapman WC; RESTORE Investigators Group. Normothermic Machine Perfusion for Declined Livers: A Strategy to Rescue Marginal Livers for Transplantation. J Am Coll Surg. 2023 Apr 1; 236 (4): 614–625. doi: 10.1097/XCS.0000000000000555. Epub 2023 Jan 11. PMID: 36728302.</mixed-citation><mixed-citation xml:lang="en">Olumba FC, Zhou F, Park Y, Chapman WC; RESTORE Investigators Group. Normothermic Machine Perfusion for Declined Livers: A Strategy to Rescue Marginal Livers for Transplantation. J Am Coll Surg. 2023 Apr 1; 236 (4): 614–625. doi: 10.1097/XCS.0000000000000555. Epub 2023 Jan 11. PMID: 36728302.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Siniscalchi A, Gamberini L, Laici C, Bardi T, Ercolani G, Lorenzini L, Faenza S. Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies. World J Gastroenterol. 2016 Jan 28; 22 (4): 1551–1569. doi: 10.3748/wjg.v22.i4.1551. PMID: 26819522; PMCID: PMC4721988.</mixed-citation><mixed-citation xml:lang="en">Siniscalchi A, Gamberini L, Laici C, Bardi T, Ercolani G, Lorenzini L, Faenza S. Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies. World J Gastroenterol. 2016 Jan 28; 22 (4): 1551–1569. doi: 10.3748/wjg.v22.i4.1551. PMID: 26819522; PMCID: PMC4721988.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Parente A, Tirotta F, Pini A, Eden J, Dondossola D, Manzia TM Dutkowski P, Schlegel A. Machine perfusion techniques for liver transplantation – A meta-analysis of the first seven randomized-controlled trials. J He¬patol. 2023 Nov; 79 (5): 1201–1213. doi: 10.1016/j.jhep.2023.05.027. Epub 2023 Jun 9. PMID: 37302578.</mixed-citation><mixed-citation xml:lang="en">Parente A, Tirotta F, Pini A, Eden J, Dondossola D, Manzia TM Dutkowski P, Schlegel A. Machine perfusion techniques for liver transplantation – A meta-analysis of the first seven randomized-controlled trials. J He¬patol. 2023 Nov; 79 (5): 1201–1213. doi: 10.1016/j.jhep.2023.05.027. Epub 2023 Jun 9. PMID: 37302578.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Tingle SJ, Dobbins JJ, Thompson ER, Figueiredo RS, Mahendran B, Pandanaboyana S, Wilson C. Machine perfusion in liver transplantation. Cochrane Database Syst Rev. 2023 Sep 12; 9 (9): CD014685. doi: 10.1002/14651858.CD014685.pub2. PMID: 37698189; PMCID: PMC10496129.</mixed-citation><mixed-citation xml:lang="en">Tingle SJ, Dobbins JJ, Thompson ER, Figueiredo RS, Mahendran B, Pandanaboyana S, Wilson C. Machine perfusion in liver transplantation. Cochrane Database Syst Rev. 2023 Sep 12; 9 (9): CD014685. doi: 10.1002/14651858.CD014685.pub2. PMID: 37698189; PMCID: PMC10496129.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Banker A, Bhatt N, Rao PS, Agrawal P, Shah M, Nayak M, Mohanka R. A Review of Machine Perfusion Strategies in Liver Transplantation. J Clin Exp Hepatol. 2023 Mar-Apr; 13 (2): 335–349. doi: 10.1016/j.jceh.2022.08.001. Epub 2022 Aug 10. PMID: 36950485; PMCID: PMC10025749.</mixed-citation><mixed-citation xml:lang="en">Banker A, Bhatt N, Rao PS, Agrawal P, Shah M, Nayak M, Mohanka R. A Review of Machine Perfusion Strategies in Liver Transplantation. J Clin Exp Hepatol. 2023 Mar-Apr; 13 (2): 335–349. doi: 10.1016/j.jceh.2022.08.001. Epub 2022 Aug 10. PMID: 36950485; PMCID: PMC10025749.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Boteon YL, Laing RW, Schlegel A, Wallace L, Smith A, Attard J et al. Combined Hypothermic and Normothermic Machine Perfusion Improves Functional Recovery of Extended Criteria Donor Livers. Liver Transpl. 2018 Dec; 24 (12): 1699–1715. doi: 10.1002/lt.25315. PMID: 30058119; PMCID: PMC6588092.</mixed-citation><mixed-citation xml:lang="en">Boteon YL, Laing RW, Schlegel A, Wallace L, Smith A, Attard J et al. Combined Hypothermic and Normothermic Machine Perfusion Improves Functional Recovery of Extended Criteria Donor Livers. Liver Transpl. 2018 Dec; 24 (12): 1699–1715. doi: 10.1002/lt.25315. PMID: 30058119; PMCID: PMC6588092.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Z, Hong X, Huang S, Wang T, Ma Y, Guo Y et al. Continuous Normothermic Machine Perfusion for Renovation of Extended Criteria Donor Livers Without Recooling in Liver Transplantation: A Pilot Experience. Front Surg. 2021 May 24; 8: 638090. doi: 10.3389/fsurg.2021.638090. PMID: 34109206; PMCID: PMC8180843.</mixed-citation><mixed-citation xml:lang="en">Chen Z, Hong X, Huang S, Wang T, Ma Y, Guo Y et al. Continuous Normothermic Machine Perfusion for Renovation of Extended Criteria Donor Livers Without Recooling in Liver Transplantation: A Pilot Experience. Front Surg. 2021 May 24; 8: 638090. doi: 10.3389/fsurg.2021.638090. PMID: 34109206; PMCID: PMC8180843.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Z, Wang T, Chen C, Zhao Q, Ma Y, Guo Y et al. Transplantation of Extended Criteria Donor Livers Following Continuous Normothermic Machine Perfusion Without Recooling. Transplantation. 2022 Jun 1; 106 (6): 1193–1200. doi: 10.1097/TP.0000000000003945. Epub 2022 Sep 7. PMID: 34495016; PMCID: PMC9128617.</mixed-citation><mixed-citation xml:lang="en">Chen Z, Wang T, Chen C, Zhao Q, Ma Y, Guo Y et al. Transplantation of Extended Criteria Donor Livers Following Continuous Normothermic Machine Perfusion Without Recooling. Transplantation. 2022 Jun 1; 106 (6): 1193–1200. doi: 10.1097/TP.0000000000003945. Epub 2022 Sep 7. PMID: 34495016; PMCID: PMC9128617.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Panconesi R, Shanmugarajah K, Satish S, Zhang M, Wehrle C, Jiao C et al. Rethinking Lactate’s Role as a Post-Transplant Outcome Predictor During Normothermic Machine Perfusion: Science or Speculation? Am J Transplant. 2025 Jan; 25 (1 Suppl 1): S126.</mixed-citation><mixed-citation xml:lang="en">Panconesi R, Shanmugarajah K, Satish S, Zhang M, Wehrle C, Jiao C et al. Rethinking Lactate’s Role as a Post-Transplant Outcome Predictor During Normothermic Machine Perfusion: Science or Speculation? Am J Transplant. 2025 Jan; 25 (1 Suppl 1): S126.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Van Leeuwen OB, de Vries Y, Fujiyoshi M, Nijsten MWN, Ubbink R, Pelgrim GJ et al. Transplantation of Highrisk Donor Livers After Ex Situ Resuscitation and Assessment Using Combined Hypo- and Normothermic Machine Perfusion: A Prospective Clinical Trial. Ann Surg. 2019 Nov; 270 (5): 906–914. doi: 10.1097/SLA.0000000000003540. PMID: 31633615.</mixed-citation><mixed-citation xml:lang="en">Van Leeuwen OB, de Vries Y, Fujiyoshi M, Nijsten MWN, Ubbink R, Pelgrim GJ et al. Transplantation of Highrisk Donor Livers After Ex Situ Resuscitation and Assessment Using Combined Hypo- and Normothermic Machine Perfusion: A Prospective Clinical Trial. Ann Surg. 2019 Nov; 270 (5): 906–914. doi: 10.1097/SLA.0000000000003540. PMID: 31633615.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
